Delivery Order SPE2DB20D6037-SPE2DB23FC9TE
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,690.11 contract is for the delivery of 10 mg dextroamphetamine-amphetamine capsules, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that allows the DLA to issue delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,360.58, is for the supply of Dextroamphetamine-Amphetamine 10 mg tablets to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order, with a performance period extending to February 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,070.32 firm fixed-price contract is for the delivery of 4,563,354,156 units of the drug dextroamphetamine-amphetamine 20 mg tablets in 100-count bottles. This order is placed under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group, which allows...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,169.87 firm fixed-price delivery order is for the supply of 4,563,991,991 tablets of 10 mg dextroamphetamine-amphetamine, a common prescription medication. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,894.21 contract is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in 100-count bottles to support the medical supply needs of the Department of Defense (DoD). The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,581.84 firm fixed-price contract is for the delivery of 4,566,225,721 units of dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of October 28, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,152.46 to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count bottles). The delivery order, which carries a firm fixed-price contract type with an ultimate completion date of September 16, 2025, does not utilize any set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,136.96 firm fixed-price contract is for the supply of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract has an ultimate completion date of July 11, 2023 and is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,526.78 award is for the delivery of 4,558,579,566 units of the prescription drug Dextroamphetamine-Amphetamine 20 mg Capsules. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a comprehensive...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB23FC9TEDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,530.05 firm fixed-price contract is for the delivery of 4,558,698,205 dextroamphetamine-amphetamine 5 mg tablets to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 7, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This IDC, along with the company's separate prime vendor contracts, solidifies its position as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to support the diverse medical needs of the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/6/22 |